ABBOTT LABORATORIES acquires Bigfoot Biomedical, Inc.

ABBOTT LABORATORIES acquired Bigfoot Biomedical, Inc., a transaction completed in September 2023.

Bigfoot Biomedical, Inc. operates in Medical devices — diabetes care, is based in Milpitas, California, USA. Bigfoot Biomedical develops connected insulin-management solutions, furthering Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.

Furthers Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.

Connected insulin-management technology that complements Abbott's FreeStyle Libre diabetes franchise. Integrated into Abbott's Diabetes Care business

On September 22, 2023, Abbott completed the acquisition of Bigfoot Biomedical, Inc. (Bigfoot), which will further Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.Abbott FY2023 10-K, Item 1 Business

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.